Rosuvastatin indications
Pro Research Analysisby 
Searched over 200M research papers for "rosuvastatin indications"
Rosuvastatin Indications: Lipid-Lowering and Cardiovascular Disease Prevention
Primary Hypercholesterolemia and Dyslipidemia Management
Rosuvastatin is widely indicated for the treatment of primary hypercholesterolemia and mixed dyslipidemia. It is highly effective at lowering low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C) 2479. Clinical trials and real-world studies confirm that rosuvastatin significantly improves lipid profiles and reduces cardiovascular risk in patients with elevated cholesterol levels 2479. Fixed-dose combinations with ezetimibe further enhance LDL-C reduction and help more patients achieve recommended cholesterol targets .
Cardiovascular Disease Prevention: Primary and Secondary
Rosuvastatin is indicated for both primary and secondary prevention of cardiovascular disease. Its potent cholesterol-lowering effect, along with additional anti-inflammatory and antioxidant properties, makes it a key therapy for reducing the risk of atherosclerotic cardiovascular events 379. Compared to other statins, rosuvastatin is more potent in lowering LDL-C and is effective in patients with or without existing cardiovascular disease 379.
Special Indications: Familial Hypercholesterolemia and Metabolic Syndrome
Rosuvastatin is also used in the management of familial hypercholesterolemia, a genetic disorder characterized by very high cholesterol levels . In patients with metabolic syndrome and moderate to severe metabolic associated fatty liver disease (MAFLD), rosuvastatin has been shown to significantly reduce liver fat content and improve lipid metabolism, with a favorable safety profile .
Heart Failure and Post-Myocardial Infarction Support
Emerging evidence suggests rosuvastatin may benefit patients with chronic heart failure by improving endothelial function, promoting tissue regeneration, and enhancing cardiac remodeling . In the context of acute myocardial infarction, rosuvastatin has been shown to improve heart function by promoting lymphangiogenesis and reducing inflammation, potentially aiding recovery after heart attacks .
Anti-Atherosclerotic and Pleiotropic Effects
Beyond cholesterol lowering, rosuvastatin exerts anti-atherosclerotic effects by improving macrophage function, reducing plaque formation, and modulating inflammatory pathways 57. These pleiotropic actions contribute to its role in preventing the progression of atherosclerosis and related complications 57.
Safety and Tolerability
Rosuvastatin is generally well tolerated, with a low rate of adverse events and no significant increase in statin-associated myopathy, hepatotoxicity, or diabetes in large observational studies . Its safety profile is comparable to other statins and combination therapies 24.
Conclusion
Rosuvastatin is primarily indicated for the management of hypercholesterolemia, prevention of cardiovascular disease, and treatment of familial hypercholesterolemia. It is also beneficial in metabolic syndrome, fatty liver disease, and may support heart function in heart failure and post-myocardial infarction settings. Its strong lipid-lowering capacity, additional vascular benefits, and favorable safety profile make it a cornerstone in cardiovascular risk management 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic